Bayer shares plunge by more than 20% after trial of potential blockbuster drug halted
Bayer lost a fifth of its market value at one point Monday, after the German pharmaceutical and agricultural group said it had ended a late-stage test for...
Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bayer lost a fifth of its market value at one point Monday, after the German pharmaceutical and agricultural group said it had ended a late-stage test for...
By Chris Wack MediciNova shares were up 14% to $2.30 after the company reported positive data for its phase 2 clinical trial of MN-166 ibudilast in...
Vertex's COO said a trial of its new pain pill hadn't tested the drug against a placebo.
Efforts to diversify clinical trials aim to ensure devices, drugs and prevention work for all
By David Sachs A drug to treat chronic liver disease developed by Ipsen and Genfit has gained a positive result in its phase-three trial, the companies said....